Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2016, Article ID 6121878, 3 pages
http://dx.doi.org/10.1155/2016/6121878
Case Report

Dementia Improvement after Plasma Exchange for Familial Hypercholesterolemia

Dementia Prevention Center, 1 Montage Mountain Road, Moosic, PA 18507, USA

Received 17 June 2016; Revised 21 August 2016; Accepted 23 August 2016

Academic Editor: Samuel T. Gontkovsky

Copyright © 2016 Allen J. Orehek. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Harvey, M. Skelton-Robinson, and M. N. Rossor, “The prevalence and causes of dementia in people under the age of 65 years,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 74, no. 9, pp. 1206–1209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. G. R. Thompson, “LDL apheresis,” Atherosclerosis, vol. 167, no. 1, pp. 1–13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. R. Williams, S. C. Hunt, M. C. Schumacher et al., “Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics,” The American Journal of Cardiology, vol. 72, no. 2, pp. 171–176, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Vella, A. A. Pineda, and T. O'Brien, “Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia,” Mayo Clinic Proceedings, vol. 76, no. 10, pp. 1039–1046, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Beigel and Y. Beigel, “Homozygous familial hypercholesterolemia: long term clinical course and plasma exchange therapy for two individual patients and review of the literature,” Journal of Clinical Apheresis, vol. 24, no. 6, pp. 219–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. G. R. Thompson, “Recommendations for the use of LDL apheresis,” Atherosclerosis, vol. 198, no. 2, pp. 247–255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Austin, J. D. Brunzell, W. L. Fitch, and R. M. Krauss, “Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 10, no. 4, pp. 520–530, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Tamai, H. Matsuoka, H. Itabe, Y. Wada, K. Kohno, and T. Imaizumi, “Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans,” Circulation, vol. 95, no. 1, pp. 76–82, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. M. H. Mokrzycki and A. A. Kaplan, “Therapeutic plasma exchange: complications and management,” American Journal of Kidney Diseases, vol. 23, no. 6, pp. 817–827, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. D. R. W. Jayne, G. Gaskin, N. Rasmussen et al., “Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis,” Journal of the American Society of Nephrology, vol. 18, no. 7, pp. 2180–2188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Tesař, E. Jelínková, Z. Mašek et al., “Influence of plasma exchange on serum levels of cytokines and adhesion molecules in ANCA-positive renal vasculitis,” Blood Purification, vol. 16, no. 2, pp. 72–80, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Keegan, F. König, R. McClelland et al., “Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange,” The Lancet, vol. 366, no. 9485, pp. 579–582, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Amieva, H. Jacqmin-Gadda, J.-M. Orgogozo et al., “The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study,” Brain, vol. 128, no. 5, pp. 1093–1101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-M. S. Leoutsakos, S. N. Forrester, C. D. Corcoran et al., “Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study,” International Journal of Geriatric Psychiatry, vol. 30, no. 8, pp. 824–832, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Gunstad, G. Strain, M. J. Devlin et al., “Improved memory function 12 weeks after bariatric surgery,” Surgery for Obesity and Related Diseases, vol. 7, no. 4, pp. 465–472, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. G. J. M. Walstra, S. Teunisse, W. A. Van Gool, and H. Van Crevel, “Reversible dementia in elderly patients referred to a memory clinic,” Journal of Neurology, vol. 244, no. 1, pp. 17–22, 1997. View at Google Scholar · View at Scopus
  17. I. Ansari and G. T. Grossberg, “Syphilis a reversible cause of dementia,” Journal of Gerontology & Geriatric Research, S4, article 003, 2015. View at Publisher · View at Google Scholar
  18. W. V. Brown, R. Brook, L. C. Hemphill, and P. M. Moriarty, “The use of lipopheresis in the practice of clinical lipidology,” Journal of Clinical Lipidology, vol. 6, no. 2, pp. 98–104, 2012. View at Publisher · View at Google Scholar · View at Scopus